Chicago, Illinois (PRWEB) June 12, 2015 - On June 12, 2015, the American Academy of Implant Dentistry awarded Dr. Jack Hahn for a lifetime of outstanding achievement. Dr. Hahn, developer of the original tapered implant and practitioner who has placed and restored over 45,000 implants over the course of his 45-year career, accepted the award at the AAID’s summer meeting, coinciding with the launch of the new Hahn™ Tapered Implant System.
The prestigious AAID award joins a long list of accolades for Dr. Hahn that includes the Aaron Gershkoff Lifetime Achievement Award, the Venue and LEAD magazine Healthcare Leadership Award, and his appointment as Board Examiner for the American Board of Oral Implantology and Implant Dentistry.
Dr. Hahn is perhaps best known for his development of the NobelReplace® dental implant, which became one of the most widely used systems in the industry. Refusing to rest on those laurels, Dr. Hahn has more recently partnered with fellow industry pioneer Jim Glidewell, owner and founder of Glidewell Laboratories, similarly known for a long career of outstanding achievements in the dental field. After two lifetimes of introducing industry-changing innovations in their respective areas of specialty, these two men have partnered on a new venture that will help reduce the cost of implant treatment so more patients can afford care.
In developing the Hahn™ Tapered Implant, Dr. Hahn and Jim Glidewell have devised a system that continues the advancement of the tapered implant and reduces treatment expenses. “We wanted to do something that would give back to an industry that has given us so much,” said Dr. Hahn. “I’ve placed over 5,000 NobelReplace implants since developing the system nearly twenty years ago, and have noticed areas for improvement. The Hahn Tapered Implant System has made these innovations a reality for the benefit of doctors and patients. Working with Glidewell Laboratories has allowed me to develop a cost-effective implant that improves the quality of treatment.”
Their collaboration represents an effort to expand the availability of implant therapy by combining Dr. Hahn’s expertise in implant design with Glidewell Laboratories’ long history of offering premium dental solutions at affordable prices. “When Jim first approached me with this idea I was honored,” said Dr. Hahn. “But I didn’t want to compromise on the quality of manufacturing if I was going to put my name on the product. What I found at the Glidewell manufacturing center in Irvine, California, convinced me that Jim was serious about this venture. He had spared no expense, and he had not cut any corners when building his state-of-the-art facility.”
Engineered to engage a maximum amount of bone and achieve a high degree of primary stability in an extensive range of clinical situations, the Hahn Tapered Implant System is the next logical step in the evolution of the tapered implant. Its design features have been carefully crafted to help clinicians mitigate patient trauma and reduce chair time, promote long-term integration, and facilitate immediate provisionalization and other prosthetic considerations. With a pronounced thread design that increases bone contact, the Hahn Tapered Implant eases control of insertion direction, positioning and angulation during placement.
Pivotal in the evolution of implant dentistry, Dr. Hahn continues to advocate simplified treatment concepts that result in long-term clinical success. Dr. Hahn has partnered with a highly experienced team of dental implant engineers, researchers and manufacturers to devise a system that makes the many benefits of implant therapy available to a larger patient population. The Hahn Tapered Implant System is the culmination of a decadeslong career that has included participation in numerous implant studies as well as long-term clinical observations of both the surgical and restorative sides of treatment.
For more information on the Hahn Tapered Implant, call 800-839-9755 or visit https://www.hahnimplant.com.
NobelReplace is a registered trademark of the Nobel Biocare group.